Epidermal growth factor in maternal urine - A predictor of intrauterine growth restriction?

Early Human Development

Volumn 56, Issue 2-3, 1999, Pages 143-150

  Lindqvist, Pelle ^a,b   Grennert, Lars ^b   Maršál, Karel ^b  

^a Central Hospital   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Epidermal growth factor; Fetal development; Screening; Urine

Indexed keywords

ANGIOGENIC FACTOR; CHORIONIC GONADOTROPIN; CREATININE; EPIDERMAL GROWTH FACTOR; MITOGENIC AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; HUMAN; HYPOTHESIS; INTRAUTERINE GROWTH RETARDATION; MOTHER; PATHOPHYSIOLOGY; PREDICTION; PREECLAMPSIA; REGRESSION ANALYSIS; SAMPLING; SCREENING; SMOKING; STATISTICAL MODEL; URINE LEVEL;

ADULT; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN; EPIDERMAL GROWTH FACTOR; FEMALE; FETAL GROWTH RETARDATION; HUMANS; LOGISTIC MODELS; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES;

EID: 0032705055     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-3782(99)00037-7     Document Type: Article

References (26)

1. Redman C.W. Current topic: pre-eclampsia and the placenta. Placenta. 12:1991;301-308.
2. Redman C.W. Platelets and the beginnings of preeclampsia. N Engl J Med. 323:1990;478-480.
3. Hofmann G.E., Rao C.V., Brown M.J., Murray L.F., Schultz G.S., Siddiqi T.A. Epidermal growth factor in urine of nonpregnant women and pregnant women throughout pregnancy and at delivery. J Clin Endocrinol Metab. 66:1988;119-123.
4. Watanabe H. Epidermal growth factor in urine of pregnant women and in amniotic fluid throughout pregnancy. Gynecol Endocrinol. 4:1990;43-50.
5. Kasai K., Nakamura T., Banba N., Ishikawa M., Konuma S., Shimoda S. Human urinary epidermal growth factor: effects of age, sex and pregnancy. Horm Res. 31:1989;157-162.
6. Hofmann G.E., Abramowicz J.S. Epidermal growth factor (EGF) concentrations in amniotic fluid and maternal urine during pregnancy. Acta Obstet Gynecol Scand. 69:1990;217-221.
7. Stoll D.M., King L.E. Jr., McNeil L., Orth D.N. Human urinary epidermal growth factor excretion: age, sex, and race dependence. J Clin Endocrinol Metab. 67:1988;361-367.
8. Shigeta K., Hiramatsu Y., Eguchi K., Sekiba K. Urinary and plasma epidermal growth factor levels are decreased in neonates with intrauterine growth retardation and in their mothers. Biol Neonate. 62:1992;76-82.
9. Tsutsumi O., Oka T. Epidermal growth factor deficiency during pregnancy causes abortion in mice. Am J Obstet Gynecol. 156:1987;241-244.
10. Kamei Y., Tsutsumi O., Kuwabara Y., Taketani Y. Intrauterine growth retardation and fetal losses are caused by epidermal growth factor deficiency in mice. Am J Physiol. 264:1993;R597-600.
11. Maruo T., Matsuo H., Oishi T., Hayashi M., Nishino R., Mochizuki M. Induction of differentiated trophoblast function by epidermal growth factor: relation of immunohistochemically detected cellular epidermal growth factor receptor levels. J Clin Endocrinol Metab. 64:1987;744-750.
12. Barnea E.R., Feldman D., Kaplan M., Morrish D.W. The dual effect of epidermal growth factor upon human chorionic gonadotropin secretion by the first trimester placenta in vitro. J Clin Endocrinol Metab. 71:1990;923-928.
13. Said M.E., Campbell D.M., Azzam M.E., MacGillivray I. Beta-human chorionic gonadotrophin levels before and after the development of pre-eclampsia. Br J Obstet Gynaecol. 91:1984;772-775.
14. Sorensen T.K., Williams M.A., Zingheim R.W., Clement S.J., Hickok D.E. Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am J Obstet Gynecol. 169:1993;834-838.
15. Marsál K., Persson P.H., Larsen T., Lilja H., Selbing A., Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 85:1996;843-848.
16. Lindqvist PG, Marsal K. Moderate smoking during pregnancy is associated with a reduced risk of preeclampsia. Acta Obstet Gynecol Scand 1999;in press.
17. Heinonen S., Ryynanen M., Kirkinen P., Saarikoski S. Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion. Am J Perinatol. 13:1996;437-441.
18. Magann E.F., Martin J.N. Jr. The laboratory evaluation of hypertensive gravidas. Obstet Gynecol Surv. 50:1995;138-145.
19. Gravett C.P., Buckmaster J.G., Watson P.T., Gravett M.G. Elevated second trimester maternal serum beta-HCG concentrations and subsequent adverse pregnancy outcome. Am J Med Genet. 44:1992;485-486.
20. Vaillant P., David E., Constant I., et al. Validity in nulliparas of increased beta-human chorionic gonadotrophin at mid-term for predicting pregnancy-induced hypertension complicated with proteinuria and intrauterine growth retardation. Nephron. 72:1996;557-563.
21. Benn P.A., Horne D., Briganti S., Rodis J.F., Clive J.M. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Obstet Gynecol. 87:1996;217-222.
22. Pergament E., Stein A.K., Fiddler M., Cho N.H., Kupferminc M.J. Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers. Obstet Gynecol. 86:1995;255-258.
23. Grunewald C. Biochemical prediction of pre-eclampsia. Acta Obstet Gynecol Scand Suppl. 164:1997;104-107.
24. Millar J.G., Campbell S.K., Albano J.D., Higgins B.R., Clark A.D. Early prediction of pre-eclampsia by measurement of kallikrein and creatinine on a random urine sample [see comments]. Br J Obstet Gynaecol. 103:1996;421-426.
25. Zaren B., Lindmark G., Bergsjo P. Hemoconcentration in smoking mothers is associated with impaired fetal growth. Acta Obstet Gynecol Scand. 76:1997;933-941.
26. Wang S.L., Lucier G.W., Everson R.B., Sunahara G.I., Shiverick K.T. Smoking-related alterations in epidermal growth factor and insulin receptors in human placenta. Mol Pharmacol. 34:1988;265-271.